The significance of host haemopoietic cells detected by cytogenetic analysis of bone marrow from recipients of bone marrow transplants
- 1 February 1986
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 62 (2) , 385-391
- https://doi.org/10.1111/j.1365-2141.1986.tb02942.x
Abstract
Summary. Bone marrow from 39 patients who received a bone marrow transplant (BMT) from a matched donor of different sex were studied by chromosome analysis for evidence of mixed haemopoietic chimaerism (MC). Recipient metaphases were detected in the bone marrow of 10 patients after BMT. Patients in whom MC was detected within 6 weeks of BMT did not all have a poor outcome. Two of seven are disease‐free survivors at > 470 and > 632 d. All three patients in whom MC was diagnosed more than 6 weeks after BMT subsequently relapsed. Four factors appear to be important in determining the probability of relapse when MC is detected in a patient after BMT: the timing of detection of residual recipient cells; the proportion of these cells in the bone marrow; persistence of these cells in increasing proportions; and the karyotype of the recipient metaphases detected. Cytogenetic assessment may provide the earliest indication of relapse in these patients. In addition, this study provides further evidence that cyclophosphamide and total body irradiation, as used in these patients, may be inadequate conditioning therapy for BMT.This publication has 13 references indexed in Scilit:
- HOW DOES BONE-MARROW TRANSPLANTATION CURE LEUKAEMIA?The Lancet, 1984
- Cytogenetic studies on recipients of allogeneic bone marrow using the sex chromosomes as markers of cellular originBritish Journal of Haematology, 1984
- DEPLETION OF T LYMPHOCYTES IN DONOR MARROW PREVENTS SIGNIFICANT GRAFT-VERSUS-HOST DISEASE IN MATCHED ALLOGENEIC LEUKAEMIC MARROW TRANSPLANT RECIPIENTSThe Lancet, 1984
- AUTOLOGOUS BONE MARROW RESCUE IS UNNECESSARY AFTER VERY-HIGH-DOSE CYCLOPHOSPHAMIDEThe Lancet, 1983
- ENDOGENOUS STEM CELL REPOPULATION RESULTING IN MIXED HEMATOPOIETIC CHIMERISM FOLLOWING TOTAL BODY IRRADIATION AND MARROW TRANSPLANTATION FOR ACUTE LEUKEMIATransplantation, 1982
- USE OF ANTI-T-CELL MONOCLONAL ANTIBODY OKT3 TO PREVENT ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ACUTE LEUKAEMIAThe Lancet, 1982
- Gene Markers in Human Bone Marrow Transplantation1Vox Sanguinis, 1977
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- New Technique for Distinguishing between Human ChromosomesNature New Biology, 1971
- Chromosome Preparatons of Bone Marrow Cells without PriorIn VitroCulture orIn VivoColchicine AdministrationStain Technology, 1962